Gene expression profiling in MDS and AML: potential and future avenues-Reference-Cited by-同舟云学术

Gene expression profiling in MDS and AML: potential and future avenues

Published:2011-03-29 Issue:6 Volume:25 Page:909-920
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Theilgaard-Mönch K,Boultwood J,Ferrari S,Giannopoulos K,Hernandez-Rivas J M,Kohlmann A,Morgan M,Porse B,Tagliafico E,Zwaan C M,Wainscoat J,Van den Heuvel-Eibrink M M,Mills K,Bullinger L

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201148.pdf

Reference104 articles.

1. Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD . Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer 2007; 7: 118–129.

2. Nimer SD . Myelodysplastic syndromes. Blood 2008; 111: 4841–4851.

3. Dohner K, Dohner H . Molecular characterization of acute myeloid leukemia. Haematologica 2008; 93: 976–982.

4. Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453–474.

5. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531–537.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Genomics and Proteomics in Drug Discovery;Interdisciplinary Biotechnological Advances;2024

2. MiR-181a-2-3p as a potential diagnostic and prognostic marker for myelodysplastic syndrome;Hematology;2022-11-29

3. Myelodysplastic Syndromes;Holland‐Frei Cancer Medicine;2022-10-21

4. Performance evaluation and clinical impact of the Oncomine Myeloid Research Assay for gene expression analysis in myeloid haematologic malignancies;Journal of Clinical Pathology;2022-08-23

5. Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome;Leukemia & Lymphoma;2022-06-11